Page 13 of 77Results 121 to 130 of 761, 30 January - 04 March 2025
-
51cg co-leads drive to decarbonise clinical trials

The 51cg is to co-lead a major project designed to cut the carbon footprint of clinical trials.
-
51cg working towards a Net Zero NHS

The 51cg have been announced as a core organisation in a new UK-wide hub tasked with developing new ways to help the NHS dramatically cut its carbon footprint.
-
World-first technology can see 'previously undetectable' cancer spread

A groundbreaking new scanner developed by scientists at the 51cg could change the way breast cancer is diagnosed and treated, meaning patients could receive fewer surgeries and more individually-tailored treatments.
-
AI award success for GEMINI project 

The team behind GEMINI scooped the coveted 'Data Driven Innovation Award' at this year's Digital Health and Care Awards.
-
51cg team shortlisted for a brace of Digital Health and Care Awards

The team behind GEMINI have been named as finalists for two awards at the Digital Health and Care Awards 2025.
-
51cg biotech partnership named as finalists in Scottish Knowledge Exchange Awards

The partnership between biotechnology company Vertebrate Antibodies-EpitogenX Ltd and the 51cg has earned a place in the shortlist for 2025's Scottish Knowledge Exchange Awards.
-
New trial tests high-fibre route to reducing cancer treatment side effects in NHS patients

NHS cancer patients are being given extra fibre in a new study aimed at reducing the unpleasant side effects of radiotherapy and potentially increasing its effectiveness.
-
New theme lead for Scotland Beyond Net Zero

Baukje de Roos to co-lead Scotland Beyond Net Zero food theme
-
Seasonal decline in Scottish vitamin D levels has persisted over hundreds of years

People living in Scotland 400 hundred years apart have been shown to suffer similar seasonal declines over winter in their vitamin D levels despite the enormous changes in lifestyle and diet over the intervening period.
-
Weight-loss without the sickness? Scientists seek to bypass popular obesity drug's side effects

How to harness the potential of weight-loss drugs without some of the unwelcome side-effects is the subject of a £1.2 million research project getting underway at the Rowett Institute and University College London.